Achieving the impossible is within reach when there is determination, though it often entails confronting unforeseen challenges. In clinical drug development, success involves uncovering possibilities amidst numerous obstacles. One of the most significant hurdles is connecting patients to appropriate clinical trials, often unknown to both patients and their physicians. Finding solutions to these complex problems is difficult, but with strong leadership, remarkable progress is possible. A visionary leader like Nuria Coll Bastus, with her expertise and foresight, can help overcome these challenges. Her innovation, Clinical Net, is a digital portal that enables anyone to quickly identify and connect with the most suitable global clinical trials at no cost.
Nuria’s journey began with her recognition of a significant issue in clinical trials: participant shortages causing delays in drug approvals. After completing her PhD and postdoctoral research, she transitioned to the pharmaceutical industry, where she identified the challenge of patient recruitment. Despite widespread willingness, 80% of trials faced delays due to this issue. Through her MBA studies, she identified the need for a user-friendly platform to match patients with relevant trials. In 2021, Nuria founded Clinical Net, a global platform that connects patients and doctors to clinical trials quickly and efficiently, revolutionizing the drug development process.
Nuria fosters a learning-driven environment, prioritizing talent and the ability to adapt over existing knowledge. She promotes transparency, encouraging team involvement in areas of passion and collaboration with external contractors, thereby expanding skills and collective expertise. For aspirants, she advises staying current with industry trends, engaging in continuous learning, and networking with peers to gain valuable insights. She emphasizes testing new technologies, maintaining flexibility, and setting aside time for strategic reflection. Nuria envisions expanding Clinical Net globally, enhancing user experience, and increasing visibility in key markets. With ongoing improvements, she aims to revolutionize clinical trial access, transforming global healthcare.
Recognized by Enterprise Review as One of The 5 Global Visionaries of the Modern Business World, Nuria’s vision and leadership continue to shape the future of clinical trials, breaking down barriers that have long hindered patient access and drug development.